Dementia is cognitive impairment often associated with old age diseases namely, Alzheimer's Disease. However, contrary to popular beliefs, dementia is divided into multiple subgroups according to age and disease progression. Interestingly, patients in the older subgroups often do not display characteristic pathologies, such as beta-amyloid plaques and neurofibrillary tangles, in high abundance as observed in patients with Alzheimer's Disease. Instead, cerebrovascular disease in the form of large or many smaller strokes is more commonly present. A notable novel observation made in the older group has been nonviable but preserved "mummified" neurons which resemble those found in an inherited, childhood disease known as pantothenate kinase associated neurodegeneration (PKAN); hence the name "PKAN neurons" for these lesions. For this project, we focused on quantifying the presence of PKAN neurons, plaques, and tangles in patients with Alzheimer's Disease (AD), mild cognitive impairment (MCI), an older subgroup of cognitive impairment designated based on their clinical and demographic features as "Disease of the Oldest Old" (DOOO), and cognitively control subjects. The PKAN neuron density was calculated to be highest in patients with DOOO (86.39 ± 17.90 N=7) when compared to the agematched control group (4.488 ± 1.274 N=6) with a p-value of 0.0015. We also noted the inverse relationship between PKAN neurons and plaques and tangles across all age-related dementia groups. Our results confirm a dichotomy of dementia in patients with clinical AD, with younger patients having a large burden of AD-associated lesions and older patients with a combination of AD lesions and inversely related PKAN neurons. The results introduce PKAN neurons recognized as a novel feature of dementia, which complement classic AD-associated lesions as correlates of cognitive impairment in more elderly patients.
Introduction
As the population ages, dementia is often attributed to known pathologies that underlie the decline of cognitive function. The most prominent old age-related pathologies, such as amyloidbeta plaques and neurofibrillary tangles, found in Alzheimer's Disease (AD) are frequently identified in patients exhibiting cognitive decline. However, it has been increasingly observed that pure AD is rarely the only drive in the manifestation of dementia, but rather it is a combination of multiple pathologies that constitutes the deterioration of the brain (Power et al., 2018; Tanskanen et al., 2017; Langka et al., 2004; Schneider, 2007) . The prevalence of multiplepathologies is highlighted in the older subset of demented group as these characteristics significantly increase dementia risk (Tanskanen et al., 2017; Rahimi and Kovacs, 2014) .
Dementia of the Oldest Old (DOOO), also known as mixed dementia, also features β-amyloid plaques and neurofibrillary tangles, which are the hallmarks of many dementia-related diseases and are characteristics of old age, but at relatively low levels of these lesions (Nelson et al., 2005, Rahimi and Kovacs, 2014) . DOOO is found most often in patients older than 80 years of age and the relative lack of accumulation of β-amyloid plaques and neurofibrillary tangles suggests that other disease processes must drive cognitive losses (Nelson et al., 2005; Crystal et al., 1993) . Commonly, it is noted that the degree of neurodegeneration might be correlated to cerebrovascular disease as multiple infarctions are found to be the second most common neuropathologic feature in older patients (Schneider, 2007; Langka et al., 2004; Tanskanen et al., 2017; Rahimi and Kovacs, 2014) . Interestingly, when observed under the microscope, we have found that patients with DOOO also have the hallmark lesions of PKAN, namely ubiquitinated ApoE-positive neurons around infarcted area of the globus pallidus, where ischemia or oxidative stress occurred (Woltjer et al., 2015) .
Patients with pantothenate kinase-associated neurodegeneration (PKAN), a rare childhood hereditary subtype of neurodegeneration with brain iron accumulation (NBIA), often exhibit movement difficulties characterized as parkinsonism and also other motor symptoms namely dystonia, choreoathetosis, corticospinal tract involvement, optic atrophy, pigmentary retinopathy, and cognitive impairment (Kruer et al., 2011; Thomas et al., 2004) . Histological findings indicate that PKAN leads to a significant neurodegeneration in the Central Nervous System (CNS) particularly in the globus pallidus characterized by iron deposition and neuroaxonal spheroids, a non-specific form of axonal degeneration (Kruer et al., 2011) . Other than the prominent accumulation of ubiquitin, apolipoprotein E (apoE)-enriched lesions have also been identified. While the role of apoE in the propagation of PKAN remains unclear, recent studies suggest the upregulation of this protein is present at sites with cellular ischemia and oxidative stress (Aoki et al., 2003; Wotljer et al., 2015) . This recent discovery allows us to infer its potential connection with cognitive impairment specifically in the older population of patients.
There were two initial observations made about PKAN neurons in patients with DOOO that prompted the closer investigations described in this study: 1. those with a modest burden of plaques and tangles but with the absence of PKAN neurons tended to stay cognitively intact when alive and 2. those with presence of PKAN neurons and absence of plagues/tangles also stayed cognitively intact. Patients with both PKAN neurons and even modest plaques and tangles, on the other hand, tend to develop cognitive impairment. These interesting observations together raise the question: What is the relative contribution of plagues, tangles, and PKAN neurons to dementia in patients who were seen at the Oregon Health and Science University (OHSU) Alzheimer's Center? In this project, we sought to perform a quantitative analysis on the presence of PKAN neurons, tangles, and plaques in three groups of cognitive impairment: Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), and Disease of the Oldest Old/Mixed Dementia (DOOO) to determine the relationship between different hallmarks of neurodegenerative diseases in an attempt to redefine dementia and confirm DOOO as a valid subgroup that is often mistaken as AD.
Materials and Methods

Human subjects
We used postmortem tissues of individuals from the Oregon Brain Bank (OBB) who had autopsy-confirmed diagnoses of AD, VCI, MCI, DOOO as well as of those with age-matched cognitively intact diagnosis. Subjects were enrolled in pre-or post-mortem study after consent was obtained from next of kin through an Oregon Health & Science University Institutional Review Board approved consent process. Patients information and histories were obtained through direct interview with family and/or review of available medical records (Woltjer et al., 2015) .
Postmortem processing
The tissues were fixed in 10% neutral buffered formalin for at least 10 days followed by dissection of frontal cortex, basal ganglia, and hippocampus. The regions were processed using standard tissue processing methods, embedded in paraffin, and cut as 7-μm paraffin sections (Kruer et al., 2011) .
Immunohistochemistry and histological evaluations
Basal ganglia paraffin sections were stained with hematoxalin and eosin (H&E) and then luxol fast blue (LFB) myelin stain to locate and evaluate the globus pallidus.
Immunohistochemical stains were applied to sections after deparaffinization and antigen retrieval (5 min after treatment at room temperature with 95% formic acid, followed by 30 min incubation in citrate buffer [pH 6 .0] at 85℃). Tissue sections were blocked with 5% nonfat dry milk in phosphate-buffered saline and stained with antibodies to 4G8 (anti-B-amyloid, mouse monoclonal from BioLegend, San Diego, CA) (1:5000); Tau (PHF-1, mouse monoclonal, a kind gift from Peter Davies, Albert Einstein College of Medicine) (1:5000); apoE (goat polyclonal from Academy Bio-Medical Co., Houston, TX) (1:5000). Results were visualized using the appropriate application of secondary antibodies and diaminobenzidine (brown) or Vector Red (Vector Laboratories) as chromagens. All slides were processed using diluted hematoxylin counterstain (Kruer et al., 2011; Woltjer et al., 2015) .
Quantification of PKAN neuron density
The globus pallidus of each case was identified and traced using H&E/LFB stained slides. The region was also marked on slide with apoE stain where PKAN neurons were located. Slide grids were adhered to each apoE slide. The biochemical characterization of PKAN neurons were based on previous studies and the density of PKAN neurons in each globus pallidus was calculated per centimeter squared (Woltjer et al, 2015) .
Quantitative assessment of tau and amyloid in frontal cortex
After the slides were stained with anti-tau and anti-amyloid antibodies, 5 representative regions of the frontal cortex of each case were photographed to be analyzed. Image analysis was done using Image J (NIH image). Due to brown color developed from the DAB chromagen, brown was set as default for signal sensitivity detection to locate plaques and tangles. Raw data was plotted and analyzed using GraphPad software. 
Results
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(B) H&E stain of PKAN neurons in globus pallidus. Note the lacy texture and uneven distribution of pink pigmentation in the background, which implies the sparse synapses and neural connections present. The absence of nuclei and nucleolus is also notable. Intracellular structure is replaced by granular substance, which is composed of remnants of disintegrated neuronal cytoplasm. (C) Immunohistochemical stain of globus pallidus containing PKAN neurons. Vector Red was used as chromagen to distinguish the dark, pink apoE heavy region from commonly found brown iron deposits found in the globus pallidus due to blood leakage. Lacy degeneration and lack of nucleus/nucleolus are also evident, showing the depletion of neural synapses (A) The neocortical plaque density using the Consortium to Establish a Registry for Alzheimer's Disease ("CERAD") plaque score assessment outlines the range of scores assigned for five subgroups: young AD, old AD, DOOO, old MCI, and control. The range of CERAD scores for young AD is 2-3, old AD is 1-2, DOOO is 0-3, old MCI is 0-2, and control is 0-1. The group scored the highest on the plaque assessment is the AD groups in which is consistent with the observation that plaques are one of the two hallmarks of the disease. (B) The presence of immunohistochemical (IHC) signal detected by 4G8 anti-amyloid antibody applied to sections of the frontal cortex varies greatly by diagnosis. There is a statistical significance between old AD and DOOO in plaques abundancy (p-value = 0.0261). There is also a statistical difference between DOOO and old control groups (p-value <0.0011). This presents that even with a small presence of plaque lesions in every old age group, these lesions are identified at a higher level in the AD groups regardless of age compared to the DOOO group. (C) The graph depicts a linear relationship between plaque scores and stain results obtained from IHC. There is a consistent relationship between the scored assigned and the staining found (pvalue < 0.0001) and that lower CERAD scores is equivalent to lower plaque lesions and higher CERAD scores is equivalent to higher plaque lesions. Control group (green dots) is clustered near the origin, indicative of little to no presence of PKAN neurons or tau signal in the group. Similarly, MCI group also features some concentration of tau and PKAN neurons but not as significantly when compared to other groups. Both AD groups (black and red dots) are heavily concentrated along the y-axis, revealing variably abundant tau signals identified with relatively low PKAN neuron density. DOOO group (purple dots) appears to be closer to the x-axis, indicative of a higher PKAN neuron count with the addition of some tangle detection. There is an inverse relationship between PKAN neurons and tangles in the older subset of demented group. The more PKAN neurons, the lower tangles detected. The lower PKAN neurons, the higher tangles detected. relative of the DOOO group. While some AD also features PKAN neurons, DOOO significantly presents a higher density.
(B) This relationship is also statistically significant (p-value =0.0036). The higher PKAN neuron density found, the lower 4G8 detection observed and vice versa, the lower PKAN neuron density found, the higher 4G8 detection observed.
Discussion
While individuals with dementia also feature plaques and tangles, they express these lesions histologically at a lower level compared to their AD counterparts (Haroutunian et al., 2008; James et al., 2012; Middleton et al., 2011; Savva et al., 2009; ) . This suggests that perhaps the presence of the pathological markers of AD are not universally applicable to all patients with dementia, particularly in the oldest old group, in which this uncategorized subset has already surpassed the age group that commonly diagnosed AD patients would fall under (Haroutunia et al., 2008; Savva et al, 2009 ). The decline in these lesions with increasing age confirms the significance of age as a contributing factor in separating the two subgroups of dementia and furthermore detaches oldest old group as its own existing pathological diagnosis from AD (Middleton et al., 2011; Haroutunian et al., 2008; Savva et al., 2009 ).
Interestingly, the new subset of dementia is commonly found to have cerebrovascular diseases and infarctions (Schneider et al., 2007; James et al., 2012) . This notable observation directs research to an entirely different route in which foretells how the manifestation of dementia might differentiate itself from AD, specifically with the recent observation of a new feature known as PKAN neurons.
The identification of PKAN neurons, in the past, has been noted in a childhood disease where these lesions were also found near areas with infarctions (Woltjer et al., 2015) . The quantitative analysis on PKAN neurons in DOOO confirms yet another feature of dementia that is beyond the realm of plaques and tangles. The correlation between PKAN neurons and cognitive impairment distinguishes DOOO from AD in which the previously identified structural changes, plaques and tangles, in cognitive impairment is insufficient to be accounted for the deterioration of the brain (James et al., 2012) . The significance of PKAN neurons further highlights that the hallmarks of dementia are not found exclusively in the frontal cortex, but it now involves the basal ganglia, namely globus pallidus, in which motor movement might be considered as a factor in diagnosing patients.
Further research is necessary to fully understand the manifestation of PKAN neurons and its association with cognitive decline. With PKAN neurons recognized as a feature of dementia, genetics information obtained from the studies of the childhood disease, PKAN, can enhance the understanding of these unique features in the DOOO subset. The recent observation about these pathologic features in globus pallidus might also lead to how the control of voluntary movement in the aging population can be studied to initiate more efforts in early detection of dementia.
